Iris H. Hall

3.8k total citations
183 papers, 3.1k citations indexed

About

Iris H. Hall is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Iris H. Hall has authored 183 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Molecular Biology, 58 papers in Organic Chemistry and 33 papers in Oncology. Recurrent topics in Iris H. Hall's work include Biochemical and Molecular Research (22 papers), Synthesis and biological activity (20 papers) and Peroxisome Proliferator-Activated Receptors (17 papers). Iris H. Hall is often cited by papers focused on Biochemical and Molecular Research (22 papers), Synthesis and biological activity (20 papers) and Peroxisome Proliferator-Activated Receptors (17 papers). Iris H. Hall collaborates with scholars based in United States, Taiwan and France. Iris H. Hall's co-authors include Kuo‐Hsiung Lee, James Chapman, C.O. Starnes, George H. Cocolas, Oi T. Wong, Thomas K. Waddell, Bernard F. Spielvogel, Kuo-Hsiung Lee, Larry J. Loeffler and Gerald Carlson and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Iris H. Hall

180 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Iris H. Hall 1.4k 1.3k 482 429 320 183 3.1k
Michael D. Threadgill 1.6k 1.1× 1.1k 0.8× 688 1.4× 481 1.1× 249 0.8× 167 3.8k
Ghanem Atassi 1.6k 1.1× 1.6k 1.2× 1.1k 2.3× 402 0.9× 318 1.0× 189 3.6k
Maciej Czerwiński 1.9k 1.3× 898 0.7× 1.1k 2.3× 405 0.9× 467 1.5× 22 4.1k
Marinella Roberti 1.6k 1.1× 1.5k 1.2× 459 1.0× 383 0.9× 475 1.5× 111 3.6k
Paul G. Grothaus 1.2k 0.8× 694 0.5× 369 0.8× 151 0.4× 594 1.9× 24 2.6k
TOMOHISA TAKITA 2.2k 1.5× 1.8k 1.4× 899 1.9× 158 0.4× 732 2.3× 175 3.9k
Chunlin Zhuang 2.4k 1.7× 1.7k 1.3× 519 1.1× 239 0.6× 519 1.6× 159 4.7k
Michael G. Malkowski 1.4k 1.0× 630 0.5× 335 0.7× 218 0.5× 1.1k 3.4× 75 3.5k
Stéphane Léonce 1.5k 1.0× 2.0k 1.5× 439 0.9× 295 0.7× 357 1.1× 119 3.2k
Curtis Hose 2.3k 1.6× 1.6k 1.2× 1.2k 2.4× 328 0.8× 511 1.6× 31 4.7k

Countries citing papers authored by Iris H. Hall

Since Specialization
Citations

This map shows the geographic impact of Iris H. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris H. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris H. Hall more than expected).

Fields of papers citing papers by Iris H. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris H. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris H. Hall. The network helps show where Iris H. Hall may publish in the future.

Co-authorship network of co-authors of Iris H. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Iris H. Hall. A scholar is included among the top collaborators of Iris H. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris H. Hall. Iris H. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hall, Iris H., et al.. (2003). Disposition and intracellular levels of moxifloxacin in human THP-1 monocytes in unstimulated and stimulated conditions. International Journal of Antimicrobial Agents. 22(6). 579–587. 9 indexed citations
2.
Evans, Michael A., Daniel C. Smith, Justin M. Holub, et al.. (2003). Synthesis and Cytotoxicity of Substituted Ethyl 2‐Phenacyl‐3‐phenylpyrrole‐4‐carboxylates. Archiv der Pharmazie. 336(3). 181–190. 15 indexed citations
3.
4.
Hall, Iris H., et al.. (2003). Cytotoxicity and mode of action of vanada- and niobatricarbadecaboranyl monohalide complexes in human HL-60 promyelocytic leukemia cells. Journal of Inorganic Biochemistry. 93(3-4). 125–131. 12 indexed citations
5.
Pettis, Ronald J., Iris H. Hall, Daniel L. Costa, & Anthony J. Hickey. (2000). Aerosol delivery of muramyl dipeptide to rodent lungs. PubMed. 2(3). 53–61. 11 indexed citations
6.
Hall, Iris H., et al.. (1999). The Hypolipidemic Activity of Heterocyclic Thiosemicarbazones,Thioureas and Their Metal Complexes in Sprague Dawley Male Rats. Metal-Based Drugs. 6(3). 143–147. 37 indexed citations
7.
Petros, William P., Joshua D. Rabinowitz, John P. Gibbs, et al.. (1998). Effect of Plasma TNF‐α on Filgrastim‐Stimulated Hematopoiesis in Mice and Humans. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(4). 816–823. 3 indexed citations
8.
Gupton, John T., et al.. (1998). Cytotoxicity of Substituted Alkyl-3,4-bis(4-methoxyphenyl)pyrrole-2-carboxylates in L1210 Lymphoid Leukemia Cells. Archiv der Pharmazie. 331(11). 337–341. 24 indexed citations
9.
Hall, Iris H., et al.. (1997). Synthesis and Cytotoxic Action of 3,5‐Isoxazolidinediones and 2‐Isoxazolin‐5‐ones in Murine and Human Tumors. Archiv der Pharmazie. 330(3). 67–73. 9 indexed citations
10.
Wong, Oi T., et al.. (1994). Hypolipidemic Activity of 4-Substituted 1,2-Diacyl-1,2,4-triazolidine-3,5-diones in Rodents. Journal of Pharmaceutical Sciences. 83(3). 367–371. 22 indexed citations
11.
Hall, Iris H., et al.. (1994). The Effects of Boron Derivatives on Lipid Absorption from theIntestine and on Bile Lipids and Bile Acids of Sprague Dawley Rats. Metal-Based Drugs. 2(2). 65–72. 3 indexed citations
12.
West, D.X., et al.. (1993). The cytotoxicity of copper(II) complexes of heterocyclic thiosemicarbazones and 2-substituted pyridine N-oxides. Anti-Cancer Drugs. 4(2). 241–250. 57 indexed citations
13.
Hall, Iris H., et al.. (1992). The Effects of N(4-Methylphenyl)diphenimide on Lipid Metabolism of Sprague Dawley Rats. Pharmaceutical Research. 9(10). 1324–1329. 1 indexed citations
14.
Chapman, Dennis E., et al.. (1991). In vivo and in vitro effects of helenalin on mouse hepatic microsomal cytochrome P450. Biochemical Pharmacology. 41(2). 229–235. 6 indexed citations
15.
Oswald, Christine, Stephen G. Chaney, & Iris H. Hall. (1990). Inhibition of DNA Synthesis in P388 Lymphocytic Leukemia Cells of BDF1 Mice by cis-Diamminedichloroplatinum(II) and Its Derivatives. Journal of Pharmaceutical Sciences. 79(10). 875–880. 1 indexed citations
16.
Hall, Iris H., et al.. (1987). Effect of Helenalin and Bis(helenalinyl)malonate on Nucleic Acid and Protein Synthesis in Human KB Carcinoma Cells. Pharmaceutical Research. 4(6). 509–514. 11 indexed citations
17.
Wong, Oi T., et al.. (1987). Synthesis and Hypolipidemic Activity of 3-Imino-l-oxoisoindolines in Rodents. Pharmaceutical Research. 4(1). 21–27. 20 indexed citations
18.
Hall, Iris H., et al.. (1987). The hypolipidemic activity of N(4-methyl-phenyl)diphenimide in rodents. Pharmacological Research Communications. 19(12). 839–858. 8 indexed citations
19.
Chapman, James, et al.. (1984). Synthesis and Evaluation of the Antitumor Properties of Esters of 2-Furoic Acid and 2-Furylacrylic Acid. Journal of Pharmaceutical Sciences. 73(2). 266–267. 8 indexed citations
20.
Baggett, Billy, et al.. (1970). Effects of two Metabolites of Norethynodrel on Reproductive Performance of Female Rats. Fertility and Sterility. 21(1). 68–72. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026